Ameriprise Financial »

Verve Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2023-09-30 $823k 62k 13.26
2023-06-30 $900k 48k 18.75
2023-03-31 $823k 57k 14.42
2022-12-31 $799k 41k 19.35
2022-09-30 $1.5M 44k 34.35
2022-06-30 $637k 42k 15.27
2022-03-31 $713k 31k 22.81
2021-12-31 $1.0M 28k 36.86
2021-09-30 $1.3M 29k 47.01
2021-06-30 $1.6M 26k 60.23